Literature DB >> 15001838

An assessment of MMP and TIMP gene expression in cell lines and stroma - tumour differences in microdissected breast cancer biopsies.

Albert S Mellick1, Daneia Blackmore, Stephen R Weinstein, Lyn R Griffiths.   

Abstract

To examine matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinases (TIMP) mRNA levels in archival breast cancer biopsies, we employed microdissection to separate tumour tissue from the surrounding breast tissue, or stroma and RT-PCR to determine gross qualitative and small quantitative differences in the patterns of expression. In this study, a significant correlation (p < 0.05, by Mann-Whitney U analysis) between TIMP-2 expression and lymph node involvement was identified, while MMP-11 and TIMP-1 expression patterning also significantly (p < 0.05) differed between those tumours showing calcification and those that did not. When compared by Spearmans' rho correlation analysis, a significant association (p < 0.05, rho = 0.404) was identified in the pattern of MMP-2 and MMP-9 gene expression. In this study, the use of microdissection and a systematic strategy of RT-PCR analysis have allowed us to investigate localized MMP and MMP inhibitor expression within breast tumours. We have identified patterns of gene expression that may further reveal aspects of breast carcinogenesis, and a robust method for examining changes in clinically important genes using archival biopsies and across stroma-tumour boundaries. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15001838     DOI: 10.1159/000076140

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  7 in total

1.  What does matrix metalloproteinase-1 expression in patients with breast cancer really tell us?

Authors:  Ferdinando Mannello
Journal:  BMC Med       Date:  2011-08-11       Impact factor: 8.775

2.  Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model.

Authors:  Odete Mendes; Hun-Taek Kim; George Stoica
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

3.  Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder.

Authors:  Christine L Chaffer; Bonnie Dopheide; Daniel R McCulloch; Allan B Lee; Jane M Moseley; Erik W Thompson; Elizabeth D Williams
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

4.  Influence of lymphatic endothelial cells on proliferation and invasiveness of esophageal carcinoma cells in vitro and lymphangiogenesis in vivo.

Authors:  Xu Yang; Nana Zhai; Miaomiao Sun; Zhihua Zhao; Jianping Yang; Kuisheng Chen; Hongxin Zhang
Journal:  Med Oncol       Date:  2015-07-23       Impact factor: 3.064

5.  Serum levels of MMP-11 correlate with clinical outcome in Chinese patients with advanced gastric adenocarcinoma.

Authors:  Dong Yan; Hong Dai; Jin-Wei Liu
Journal:  BMC Cancer       Date:  2011-04-24       Impact factor: 4.430

6.  Novel STAT binding elements mediate IL-6 regulation of MMP-1 and MMP-3.

Authors:  Samuel J Cutler; James D Doecke; Ibtisam Ghazawi; Jinbo Yang; Lyn R Griffiths; Kevin J Spring; Stephen J Ralph; Albert S Mellick
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

7.  A meta analysis of pancreatic microarray datasets yields new targets as cancer genes and biomarkers.

Authors:  Nalin C W Goonesekere; Xiaosheng Wang; Lindsey Ludwig; Chittibabu Guda
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.